Mortality-related Risks in treatment-naive Hospitalized Aids Patients With Opportunistic Infections in Southwest China

References

• Komninakis SV , MotaML, HunterJR, DiazRS. Late presentation HIV/AIDS is still a challenge in Brazil and worldwide. AIDS Res. Hum. Retroviruses, 34(2), 129–131 (2018).
   PubMed Web of Science ®Google Scholar
• Li Z , TengZ, MiaoH. Modeling and control for HIV/AIDS transmission in China based on data from 2004 to 2016. Comput. Math. Methods Med., 2017, 8935314 (2017).
   Web of Science ®Google Scholar
• Sun JJ , LuHZ. [Highlights of the third edition of Chinese guidelines for AIDS diagnosis and treatment (2015)]. Zhejiang Da Xue Xue Bao Yi Xue Ban, 44(6), 597–602 (2015).
   PubMedGoogle Scholar
• Kim YJ , WooJH, KimMJet al. Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV/AIDS cohort study, 2006 to 2013. Korean J. Intern. Med., 31(5), 953–960 (2016).
   PubMed Web of Science ®Google Scholar
• Alfven T , ErkkolaT, GhysPDet al. Global AIDS reporting-2001 to 2015: lessons for monitoring the sustainable development goals. AIDS Behav., 21(Suppl. 1), 5–14 (2017).
   PubMedGoogle Scholar
• Engsig FN , ZangerleR, KatsarouOet al. Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery. Clin. Infect. Dis., 58(9), 1312–1321 (2014).
   PubMed Web of Science ®Google Scholar
• Moore RD , KerulyJC. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin. Infect. Dis., 44(3), 441–446 (2007).
   PubMed Web of Science ®Google Scholar
• Masur H , BrooksJT, BensonCAet al. Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: updated guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin. Infect. Dis., 58(9), 1308–1311 (2014).
   PubMed Web of Science ®Google Scholar
• Rodger AJ , FoxZ, LundgrenJDet al. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection. J. Infect. Dis., 200(6), 973–983 (2009).
   PubMed Web of Science ®Google Scholar
• Boulware DR , HullsiekKH, PuronenCEet al. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J. Infect. Dis., 203(11), 1637–1646 (2011).
   PubMed Web of Science ®Google Scholar
• Crum NF , RiffenburghRH, WegnerSet al. Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras. J. Acquir. Immune Defic. Syndr., 41(2), 194–200 (2006).
   PubMed Web of Science ®Google Scholar
• Kim YJ , WooJH, KimMJet al. Opportunistic diseases among HIV-infected patients: a multicenter-nationwide Korean HIV/AIDS cohort study, 2006 to 2013. Korean J. Intern. Med., 31(5), 953–960 (2016).
   PubMed Web of Science ®Google Scholar
• Xiao J , GaoG, LiYet al. Spectrums of opportunistic infections and malignancies in HIV-infected patients in tertiary care hospital, China. PLoS ONE, 8(10), e75915 (2013).
   PubMed Web of Science ®Google Scholar
• Luo B , SunJ, CaiRet al. Spectrum of opportunistic infections and risk factors for in-hospital mortality of admitted AIDS patients in Shanghai. Medicine (Baltimore), 95(21), e3802 (2016).
   PubMed Web of Science ®Google Scholar
• Yang R , ZhangH, XiongYet al. Molecular diagnosis of central nervous system opportunistic infections and mortality in HIV-infected adults in Central China. AIDS Res. Ther., 14, 24 (2017).
   PubMed Web of Science ®Google Scholar
• Pang W , ShangP, LiQet al. Prevalence of opportunistic infections and causes of death among hospitalized HIV-infected patients in Sichuan, China. Tohoku J. Exp. Med., 244(3), 231–242 (2018).
   PubMed Web of Science ®Google Scholar
• Lavreys L , BaetenJM, ChohanVet al. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin. Infect. Dis., 42(9), 1333–1339 (2006).
   PubMed Web of Science ®Google Scholar
• Hoffmann CJ , SchomakerM, FoxMPet al. CD4 count slope and mortality in HIV-infected patients on antiretroviral therapy: multicohort analysis from South Africa. J. Acquir. Immune Defic. Syndr., 63(1), 34–41 (2013).
   PubMed Web of Science ®Google Scholar
• Gohil SK , HeoM, SchoenbaumEE, CelentanoD, PirofskiLA. CD8+ T cells and risk for bacterial pneumonia and all-cause mortality among HIV-infected women. J. Acquir. Immune Defic. Syndr., 60(2), 191–198 (2012).
   PubMed Web of Science ®Google Scholar
• Shearer WT , EasleyKA, GoldfarbJet al. Evaluation of immune survival factors in pediatric HIV-1 infection. Ann. NY Acad. Sci., 918, 298–312 (2000).
   PubMed Web of Science ®Google Scholar
• Feili L , YanyingH, FengYet al. Value of C-reactive protein in assessing illness severity and predicting prognosis for patients with HIV/AIDS. Chin. J. Exp. Clin. Infect. Dis., 9(4), 498–501 (2015).
   Google Scholar
• Bennett CL , WeinsteinRA, ShapiroMFet al. A rapid preadmission method for predicting inpatient course of disease for patients with HIV-related Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med., 150(6 Pt 1), 1503–1507 (1994).
   PubMed Web of Science ®Google Scholar
• Sage EK , NoursadeghiM, EvansHEet al. Prognostic value of C-reactive protein in HIV-infected patients with Pneumocystis jirovecii pneumonia. Int. J. STD AIDS, 21(4), 288–292 (2010).
   PubMed Web of Science ®Google Scholar
• Strategies for Management of Antiretroviral Therapy Study Group , El-SadrWM, LundgrenJet al.CD4+ count-guided interruption of antiretroviral treatment. N. Engl. J. Med., 355(22), 2283–2296 (2006).
   PubMed Web of Science ®Google Scholar
• Neuhaus J , JacobsDRJr, BakerJVet al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J. Infect. Dis., 201(12), 1788–1795 (2010).
   PubMed Web of Science ®Google Scholar
• Shivakoti R , YangWT, GupteNet al. Concurrent anemia and elevated C-reactive protein predicts HIV clinical treatment failure, including tuberculosis, after antiretroviral therapy initiation. Clin. Infect. Dis., 61(1), 102–110 (2015).
   PubMed Web of Science ®Google Scholar
• Lederman MM , FunderburgNT, SekalyRP, KlattNR, HuntPW. Residual immune dysregulation syndrome in treated HIV infection. Adv. Immunol., 119, 51–83 (2013).
   PubMed Web of Science ®Google Scholar
• Wang L , ZhouKH, ZhaoHPet al. The characteristics of screening and confirmatory test results for HIV in Xi’an, China. PLoS ONE, 12(7), e0180071 (2017).
   PubMed Web of Science ®Google Scholar